BioScience Health Innovations, Inc. (BHIC)
OTCMKTS · Delayed Price · Currency is USD
2.200
+0.118 (5.69%)
At close: Apr 2, 2026

BHIC Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
0.640.09-0.25-0.17-0.01
Stock-Based Compensation
---00.01
Other Operating Activities
-0.06----
Change in Accounts Receivable
-0.3-0.06-0.03-0.01-
Change in Inventory
-0.28-0.02-0.03-0.01-
Change in Accounts Payable
-00-0.01--
Change in Unearned Revenue
0.110.020--
Change in Other Net Operating Assets
0.06-0000
Operating Cash Flow
0.170.02-0.31-0.180
Operating Cash Flow Growth
642.53%----
Sale (Purchase) of Intangibles
-0.06-0.03---
Investing Cash Flow
-0.06-0.03---
Short-Term Debt Issued
3.050.960.610.18-
Total Debt Issued
3.050.960.610.18-
Short-Term Debt Repaid
-3.16-1.07-0.57-0.13-
Total Debt Repaid
-3.16-1.07-0.57-0.13-
Net Debt Issued (Repaid)
-0.12-0.110.040.04-
Issuance of Common Stock
-0.760.270.15-
Other Financing Activities
--0.01--
Financing Cash Flow
-0.120.650.320.19-
Net Cash Flow
-00.640.010.010
Levered Free Cash Flow
-0.13-0.06-0.2-0.08-
Unlevered Free Cash Flow
-0.13-0.06-0.2-0.08-
Change in Working Capital
-0.41-0.06-0.06-0.020
Source: S&P Global Market Intelligence. Standard template. Financial Sources.